Recognizing and managing a malignant hyperthermia crisis: guidelines from the European Malignant Hyperthermia Group

K P E Glahn, F R Ellis, P J Halsall, C R Müller, M M J Snoeck, A Urwyler, F Wappler, European Malignant Hyperthermia Group

152 Citationer (Scopus)

Abstract

Survival from a malignant hyperthermia (MH) crisis is highly dependent on early recognition and prompt action. MH crises are very rare and an increasing use of total i.v. anaesthesia is likely to make it even rarer, leading to the potential risk of reduced awareness of MH. In addition, dantrolene, the cornerstone of successful MH treatment, is unavailable in large areas around the world thereby increasing the risk of MH fatalities in these areas. The European Malignant Hyperthermia Group collected and reviewed all guidelines available from the various MH centres in order to provide a consensus document. The guidelines consist of two textboxes: Box 1 on recognizing MH and Box 2 on the treatment of an MH crisis.
OriginalsprogEngelsk
TidsskriftBritish Journal of Anaesthesia
Vol/bind105
Udgave nummer4
Sider (fra-til)417-20
Antal sider4
ISSN0007-0912
DOI
StatusUdgivet - 1 okt. 2010

Fingeraftryk

Dyk ned i forskningsemnerne om 'Recognizing and managing a malignant hyperthermia crisis: guidelines from the European Malignant Hyperthermia Group'. Sammen danner de et unikt fingeraftryk.

Citationsformater